Transesophageal echocardiography as a tool in the evaluation of patients with embolic disorders.
TEE has become one of the most powerful tools for evaluating patients with unexplained stroke, TIA, and peripheral and pulmonary embolization. This is especially encouraging in view of the previously disappointing results of TTE in these patients. In addition to the dramatic results in terms of clot visualization and the other intracardiac sources of embolization described previously, a new extracardiac source has been identified, namely protruding atheromas in the thoracic aorta. These atheromas have been seen for the first time because of the new diagnostic window that has been opened by the development of TEE. Their recognition and follow-up may lead to information that will change the approach to a significant number of patients with embolic ischemic episodes.
Kronzon
I
I
Department of Medicine, New York University Medical Center, NY 10016.
Tunick
P A
PA
D001018:Aortic Diseases / Q000000981:diagnostic imaging; D002114:Calcinosis / Q000000981:diagnostic imaging; D009202:Cardiomyopathies / Q000000981:diagnostic imaging; D004452:Echocardiography / Q000379:methods; D004617:Embolism / Q000000981:diagnostic imaging* / Q000209:etiology; D004697:Endocarditis, Bacterial / Q000000981:diagnostic imaging; D006331:Heart Diseases / Q000150:complications / Q000000981:diagnostic imaging*; D006350:Heart Valve Prosthesis; D006801:Humans; D011475:Prosthesis Failure; D011655:Pulmonary Embolism / Q000000981:diagnostic imaging / Q000209:etiology; D013927:Thrombosis / Q000150:complications / Q000000981:diagnostic imaging*